相关实验视频

Updated: Jul 14, 2025

Adenoviral Gene Therapy for Diabetic Keratopathy: Effects on Wound Healing and Stem Cell Marker Expression in Human Organ-cultured Corneas and Limbal Epithelial Cells

Adenoviral Gene Therapy for Diabetic Keratopathy: Effects on Wound Healing and Stem Cell Marker Expression in Human Organ-cultured Corneas and Limbal Epithelial Cells

Published on: April 7, 2016

局部胰岛素是一种新型的角膜上皮再生剂,用于干眼疾病

Barbara Burgos-Blasco¹, David Diaz-Valle^1,2, Daniela Rego-Lorca¹

¹Servicio de Oftalmología, Instituto de Investigación Sanitaria, Hospital Clínico San Carlos (IdISSC), Hospital Clinico San Carlos, Madrid, Spain.

European journal of ophthalmology

|October 10, 2023

概括

局部胰岛素眼液在治疗干眼病方面表现有前途,显著减少角膜染色和改善患者症状. 这种非标签性治疗在耐火性上皮损伤患者的病例系列中得到了很好的耐受.

科学领域:

眼科医生眼科眼科
再生医学是一种再生医学.

背景情况:

干眼病 (DED) 是一种普遍的疾病,导致眼部不适和视觉障碍.
在DED中,耐火性上皮损伤构成了重大的治疗挑战.
目前的治疗方法可能对所有患者都不够,需要新的方法.

研究的目的:

评估局部胰岛素眼滴在治疗干眼疾病中的疗效.
评估胰岛素眼滴对角膜染色和患者报告的症状的影响.

主要方法:

一个回顾性病例系列,涉及16名被诊断患有干眼病和上皮损伤的患者.
患者接受了非标签局部胰岛素眼滴.
关于症状,结膜高血症和角膜染色的数据在基线和3个月后收集.

主要成果:

局部胰岛素治疗导致3个月后报告的症状 (p=0.001),结膜高血症 (p<0.001) 和角膜染色 (p<0.001) 显著减少.
超过69%的患者报告主观改善 (更好或更好).
治疗耐受性很好,没有报告任何不良事件.

结论:

局部胰岛素显示出作为干眼疾病的安全有效治疗选择的潜力,特别是在长期表皮损伤的情况下.
需要进一步的研究,包括更大的受控试验,以证实这些发现.

关键词:

眼睛干燥眼睛干燥眼睛滴水眼睛滴水在这种情况下,胰岛素胰岛素胰岛素.眼睛表面的表面是眼睛的表面.

更多相关视频

Author Spotlight: Exploring Corneal Innate Immunity and Delayed Wound Healing in Diabetic Patients

Author Spotlight: Exploring Corneal Innate Immunity and Delayed Wound Healing in Diabetic Patients

Published on: January 10, 2025

Production of Modified Autologous Conditioned Serum and Ex Vivo Assessment of Its Healing Potential in Murine Corneal Epithelium

Production of Modified Autologous Conditioned Serum and Ex Vivo Assessment of Its Healing Potential in Murine Corneal Epithelium

Published on: March 24, 2023

相关概念视频

Clinical Applications of Epidermal Stem Cells

Clinical Applications of Epidermal Stem Cells

Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...